Status:
NOT_YET_RECRUITING
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Recurrent Ovarian Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential t...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years old
- Able to comprehend the investigational nature of the protocol and provide informed consent
- Diagnosis of recurrent ovarian cancer
Exclusion
- No diagnosis of recurrent ovarian cancer confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06070285
Start Date
October 1 2024
End Date
October 1 2026
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107